Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Data abstractedfrom ACC15 AbstractA1363, PooledSafetyandAdverseEventsinNine Randomized,
Placebo-Controlled,Phase 2andPhase...
Upcoming SlideShare
Loading in …5
×

0

Share

Download to read offline

Alirocumab effect on new-onset or worsening diabetes, blood glucose, and HbA1c.

Download to read offline

Data abstracted from ACC15 Abstract A1363. JACC March 17, 2015, Volume 65, Issue 10S.

Related Books

Free with a 30 day trial from Scribd

See all

Related Audiobooks

Free with a 30 day trial from Scribd

See all
  • Be the first to like this

Alirocumab effect on new-onset or worsening diabetes, blood glucose, and HbA1c.

  1. 1. Data abstractedfrom ACC15 AbstractA1363, PooledSafetyandAdverseEventsinNine Randomized, Placebo-Controlled,Phase 2andPhase 3 Clinical Trialsof Alirocumab. J Am Coll Cardiol. 2015; 65(10_S). doi: 10.1016/S0735-1097(15)61363-8. Alirocumab Placebo N=2482 N=1277 Adverse events,%(n) Anytreatment-emergent diabetesorworseningof preexistingdiabetes 3.4 (83) 3.1 (40) Otherclinical laboratorydata. Week52 change frombaseline. N=2318 N=1174 Fastingglucose,mmol/L,mean (SD) 0.16 (1.52) 0.13 (1.64) HemoglobinA1c%,mean(SD) 0.10 (0.66) 0.07 (0.54)

Data abstracted from ACC15 Abstract A1363. JACC March 17, 2015, Volume 65, Issue 10S.

Views

Total views

6,567

On Slideshare

0

From embeds

0

Number of embeds

5,428

Actions

Downloads

2

Shares

0

Comments

0

Likes

0

×